These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 1711448)

  • 21. The safety of amlodipine.
    Osterloh I
    Am Heart J; 1989 Nov; 118(5 Pt 2):1114-9; discussion 1119-20. PubMed ID: 2573265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
    Waeber B; Borges ET; Christeler P; Guillaume-Gentil M; Hollenstein U; Mannhart M
    Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparison between amlodipine and nifedipine retard in patients with essential arterial hypertension].
    Terrachini V; Canale C; Lonati A; Masperone MA; Bruzzone F; Malvestiti FM; Caponnetto S
    Clin Ter; 1992 Apr; 140(4):383-9. PubMed ID: 1534044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic profile of amlodipine.
    Burges RA; Dodd MG; Gardiner DG
    Am J Cardiol; 1989 Nov; 64(17):10I-18I; discussion 18I-20I. PubMed ID: 2554708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of amlodipine.
    Meredith PA; Elliott HL
    Clin Pharmacokinet; 1992 Jan; 22(1):22-31. PubMed ID: 1532771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of amlodipine.
    Abernethy DR
    Cardiology; 1992; 80 Suppl 1():31-6. PubMed ID: 1534713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
    Katz AM; Leach NM
    J Clin Pharmacol; 1987 Nov; 27(11):825-34. PubMed ID: 3323259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of amlodipine in the management of ischaemic heart disease.
    McGibney D
    Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amlodipine].
    Pedersen OL; Schroeder P
    Ugeskr Laeger; 1991 Jul; 153(28):2021-3. PubMed ID: 1830707
    [No Abstract]   [Full Text] [Related]  

  • 30. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
    Croom KF; Wellington K
    Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of mild to moderate hypertension. Efficacy and tolerance of Amlodipine in comparison with the combination nifedipine/mefruside].
    Höfling B; Häringer E; Herrmann W; Pieske H; Pieske R; Philippi M
    Fortschr Med; 1991 May; 109(15):327-30. PubMed ID: 1830287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amlodipine and captopril in moderate-severe essential hypertension.
    Maclean D; Mitchell ET; Wilcox RG; Walker P; Tyler HM
    J Hum Hypertens; 1988 Aug; 2(2):127-32. PubMed ID: 2977406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlodipine in hypertension: an overview of the clinical dossier.
    Julius S
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S27-33. PubMed ID: 2467123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
    Murdoch D; Brogden RN
    Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine.
    Elliott HL; Meredith PA
    Postgrad Med J; 1991; 67 Suppl 3():S20-3. PubMed ID: 1836870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.